Login / Signup

Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study.

François BardeRoberta LorenzonEric VicautSébastien RivièrePatrice CacoubCarlotta CacciatoreMichelle RosenzwajgAnne Daguenel-NguyenOlivier FainDavid KlatzmannArsenne Mekinian
Published in: RMD open (2024)
therapeutic efficacy in SSc.
Keyphrases
  • systemic sclerosis
  • regulatory t cells
  • low dose
  • interstitial lung disease
  • open label
  • dendritic cells
  • clinical trial
  • high dose
  • randomized controlled trial
  • squamous cell carcinoma
  • immune response
  • radiation therapy